General Updates

Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 23 September 2026 Corporate relationship Department, National Stock Exchange of India, Limited BSE Limited, Exchange Plaza, 5th Floor, 1st Floor, Rotunda Building Plot No. C/1, G Block, Bandra-Kurla Complex, P.J Towers Dalal Street, Fort, Bandra (E), Mumbai 400001 Mumbai 400051 Stock Code: BSE – 530549 / NSE – SHILPAMED Dear Sir/Ma’am, Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Assignment of ESG Rating by CRISIL ESG Ratings. This is to inform you that CRISIL ESG Ratings & Analytics Limited (CRISL ESG Ratings), vide summary of its report received by the Company on 22 September 2026, has assigned an Environmental, Social and Governance (ESG) score of “Crisil ESG 59” to the Company, based on disclosures for fiscal 2026 and other publicly available data. It may please be noted that the Company has not engaged CRISIL ESG Ratings for the said rating. The same has been independently prepared by CRISIL ESG Ratings based on information available in the public domain. The disclosure is made pursuant to Regulation 30 and SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated 30th January 2026. This is for your information and records. For SHILPA MEDICARE LIMITED Ritu Tiwary Company Secretary & Compliance Officer